141 related articles for article (PubMed ID: 19190136)
21. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
22. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women.
Cai H; Xiang YB; Qu S; Long J; Cai Q; Gao J; Zheng W; Shu XO
Am J Epidemiol; 2011 Jun; 173(11):1263-71. PubMed ID: 21454826
[TBL] [Abstract][Full Text] [Related]
23. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
[TBL] [Abstract][Full Text] [Related]
24. Influence of polymorphisms in MTHFR 677 C→T, TYMS 3R→2R and MTR 2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC.
Cui LH; Yu Z; Zhang TT; Shin MH; Kim HN; Choi JS
Pharmacogenomics; 2011 Jun; 12(6):797-808. PubMed ID: 21605004
[TBL] [Abstract][Full Text] [Related]
25. The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence.
Cavic M; Krivokuca A; Spasic J; Brotto K; Malisic E; Radosavljevic D; Radulovic S; Jankovic R
J BUON; 2014; 19(4):1024-8. PubMed ID: 25536611
[TBL] [Abstract][Full Text] [Related]
26. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
Setiawan VW; Doherty JA; Shu XO; Akbari MR; Chen C; De Vivo I; Demichele A; Garcia-Closas M; Goodman MT; Haiman CA; Hankinson SE; Henderson BE; Horn-Ross PL; Lacey JV; Le Marchand L; Levine DA; Liang X; Lissowska J; Lurie G; McGrath M; Narod SA; Rebbeck TR; Ursin G; Weiss NS; Xiang YB; Yang HP; Zheng W; Olson SH
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):242-7. PubMed ID: 19124504
[TBL] [Abstract][Full Text] [Related]
27. Gene Polymorphisms Involved in Folate Metabolism and DNA Methylation with the Risk of Head and Neck Cancer.
De Castro TB; Rodrigues-Fleming GH; Oliveira-Cucolo JG; Silva JNGD; Silva FP; Raposo LS; Maniglia JV; Pavarino EC; Batista Arantes LMR; Galbiatti-Dias ALS; Maria Goloni Bertollo E
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3751-3759. PubMed ID: 33369477
[TBL] [Abstract][Full Text] [Related]
28. Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
Terry K; McGrath M; Lee IM; Buring J; De Vivo I
Gynecol Oncol; 2010 May; 117(2):255-9. PubMed ID: 20199803
[TBL] [Abstract][Full Text] [Related]
29. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
Oosterom N; Berrevoets M; den Hoed MAH; Zolk O; Hoerning S; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
Pharmacogenet Genomics; 2018 Oct; 28(10):223-229. PubMed ID: 30222710
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation in CYP17 and endometrial cancer risk.
Gaudet MM; Lacey JV; Lissowska J; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
Hum Genet; 2008 Mar; 123(2):155-62. PubMed ID: 18172694
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
32. Genetic variation in the androgen receptor gene and endometrial cancer risk.
Yang HP; Garcia-Closas M; Lacey JV; Brinton LA; Lissowska J; Peplonska B; Chanock S; Gaudet MM
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):585-9. PubMed ID: 19190146
[TBL] [Abstract][Full Text] [Related]
33. The Asp(327)Asn polymorphism in the sex hormone-binding globulin gene modifies the association of soy food and tea intake with endometrial cancer risk.
Xu WH; Zheng W; Cai Q; Cheng JR; Cai H; Xiang YB; Shu XO
Nutr Cancer; 2008; 60(6):736-43. PubMed ID: 19005973
[TBL] [Abstract][Full Text] [Related]
34. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
35. Thymidylate synthase pharmacogenetics.
Marsh S
Invest New Drugs; 2005 Dec; 23(6):533-7. PubMed ID: 16267625
[TBL] [Abstract][Full Text] [Related]
36. Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita.
Tummala H; Walne A; Buccafusca R; Alnajar J; Szabo A; Robinson P; McConkie-Rosell A; Wilson M; Crowley S; Kinsler V; Ewins AM; Madapura PM; Patel M; Pontikos N; Codd V; Vulliamy T; Dokal I
Am J Hum Genet; 2022 Aug; 109(8):1472-1483. PubMed ID: 35931051
[TBL] [Abstract][Full Text] [Related]
37. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
38. Distribution of the most common polymorphisms in TYMS gene in Slavic population of central Europe.
Pastorakova A; Chandogova D; Chandoga J; Luha J; Bohmer D; Malova J; Braxatorisova T; Juhosova M; Reznakova S; Petrovic R
Neoplasma; 2017; 64(6):962-970. PubMed ID: 28895423
[TBL] [Abstract][Full Text] [Related]
39. Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer.
Shi Q; Zhang Z; Neumann AS; Li G; Spitz MR; Wei Q
Carcinogenesis; 2005 Mar; 26(3):649-56. PubMed ID: 15579479
[TBL] [Abstract][Full Text] [Related]
40. Association between 5'-UTR and 3'-UTR Polymorphisms of the TYMS Gene and Breast Cancer in Kurdish Women of Iraq.
Mohamad KS
Asian Pac J Cancer Prev; 2021 May; 22(5):1557-1560. PubMed ID: 34048185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
